ReShape Lifesciences shares are trading higher after the company announced that it received a notice of allowance for its U.S. patent application 17/572,387 titled "INTRAGASTRIC DEVICE (FOR TREATING OBESITY)"
Portfolio Pulse from Benzinga Newsdesk
ReShape Lifesciences shares are trading higher after the company announced that it received a notice of allowance for its U.S. patent application 17/572,387 titled 'INTRAGASTRIC DEVICE (FOR TREATING OBESITY)'.
May 29, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ReShape Lifesciences shares are trading higher following the announcement of a notice of allowance for its U.S. patent application for an intragastric device aimed at treating obesity.
The notice of allowance for the patent application is a significant milestone for ReShape Lifesciences, indicating that the patent is likely to be granted. This development is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100